Researchers at NYU Grossman School of Medicine, collaborating through the International Milk Composition Consortium, identified seven key biomarkers that bridge the gap between maternal physiology and child development. By integrating data on metabolites, proteins, and micronutrients, the team linked these markers to three critical mammary functions: milk synthesis, tissue remodeling, and immune activity.

Among these indicators, short-chain acylcarnitines emerged as central signals, with C5 levels showing a particularly strong correlation with reduced milk synthesis and altered tissue repair. The research suggests that low levels of vitamin B5 may constrain coenzyme A metabolism, potentially disrupting these pathways. This discovery suggests that the mammary gland is not merely a conduit for nutrients but a dynamic organ that programs the maternal-infant connection after birth. The team is now investigating whether targeted nutritional interventions can optimize these metabolic pathways to better support infant outcomes.